Effect of a Cooling Sensation Flavor on the Swallow Response in Post-stroke Patients With Oropharyngeal Dysphagia

NCT ID: NCT06250426

Last Updated: 2024-02-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-10-21

Study Completion Date

2025-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Current oropharyngeal dysphagia (OD) treatment in older patients is based on compensatory strategies (fluid thickening and texture modified diets) that improve swallow safety but do not improve the swallowing function. One of these strategies is thickening products, which are used to reduce pharyngeal bolus velocity by increasing viscosity of fluids. There are several studies demonstrating the therapeutic effect of thickeners in reducing the prevalence of penetrations and aspirations, and their use has been correlated with reduced prevalence of respiratory infections, aspiration pneumonia and hospital readmissions.

In recent years, new neurorehabilitation treatment strategies for OD have been developed such as peripheral (electrical or chemical stimulation) or central stimulation (transcranial direct current stimulation or repetitive transcranial magnetic stimulation).

The investigators suggest that new generation treatments for OD have to combine thickened fluids and about peripheral stimulation using transient receptor potential (TRP) channels agonists. The aim of this study is to evaluate the therapeutic effect of a cooling sensation (CS) flavor in a pre-thickened oral nutritional supplement (ONS) drink on the biomechanical mechanism of the swallow response in chronic post-stroke patients with OD.

The investigators designed a randomized, crossover, interventional and open-label clinical study. The study includes 2 groups: 1) n=25: 1st visit: stimulation with Control, 2nd visit: stimulation with CS; and 2) n=25: 1st visit: stimulation with CS, 2nd visit: stimulation with Control. Each patient will attend a total of 2 visits, with a washing period of at least 7 days between visits. The procedures to be performed during each visit are: clinical assessment of swallowing with V-VST, spontaneous swallowing frequency measurement using electromyography, and collection of a sample of saliva using a Salivette®.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Oropharyngeal Dysphagia Stroke Swallowing Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Randomized, crossover, interventional and, open-label clinical study. The study includes 2 groups: 1) n=25: 1st visit: stimulation with Control, 2nd visit: stimulation with CS; and 2) n=25: 1st visit: stimulation with CS, 2nd visit: stimulation with Control.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Active

Pre-thickened oral nutritional supplement with a cooling sensation flavour

Group Type ACTIVE_COMPARATOR

Pre-thickened oral nutritional supplement with a cooling sensation flavour

Intervention Type DIETARY_SUPPLEMENT

Pre-thickened oral nutritional supplement (ONS) drink with cooling sensation flavour

Control

Pre-thickened oral nutritional supplement without a cooling sensation flavour

Group Type PLACEBO_COMPARATOR

Pre-thickened oral nutritional supplement without a cooling sensation flavour

Intervention Type DIETARY_SUPPLEMENT

Pre-thickened oral nutritional supplement (ONS) drink without cooling sensation flavour

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pre-thickened oral nutritional supplement with a cooling sensation flavour

Pre-thickened oral nutritional supplement (ONS) drink with cooling sensation flavour

Intervention Type DIETARY_SUPPLEMENT

Pre-thickened oral nutritional supplement without a cooling sensation flavour

Pre-thickened oral nutritional supplement (ONS) drink without cooling sensation flavour

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ≥18 years
* Patients with chronic OD as a consequence of stroke (more than 3 month since stroke diagnostic)
* Patients with impaired safety and/or efficacy of swallow (V-VST)
* Patients that can swallow safely the investigation and control product according to the viscosity of the product and the results of the V-VST
* Patients able to follow the protocol and give informed consent

Exclusion Criteria

* Pregnancy
* Life expectancy \<3 months or palliative care
* OD diagnosis prior to stroke
* Dementia (GDS 4 or higher)
* Allergy to the investigation and/or control product or to any of its components
* Participation in another interventional study in the month prior to inclusion
* Current users of a pre-thickened ONS drink with cooling sensation flavor
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nutricia Research

INDUSTRY

Sponsor Role collaborator

Hospital de Mataró

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Pere Clave

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital de Mataró

Mataró, Barcelona, Spain

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Pere Clavé, MD, PhD

Role: CONTACT

937417700 ext. 2284

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Pere Clavé, MD

Role: primary

937417700 ext. 2284

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Refresh

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.